Yubo International Biotech Limited Revenue per Employee (MAGAA), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Yubo International Biotech Limited  (MAGAA)
 

Yubo International Biotech Limited's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Yubo International Biotech Limited's Revenue per employee fell on a trailing twelve month basis to $ 882, but the productivity of Yubo International Biotech Limited's employees remained above the company average.
Within the Healthcare sector Yubo International Biotech Limited achieved the highest revenue per employee. While revenue per employee remained unchanged compared to the previous quarter at no. .Yubo International Biotech Limited has 14 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MAGAA Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change - - - - -
Sales per Employee (TTM) $ 882 882 882 - -
MAGAA's Total Ranking # # # # #
Seq. Revenue Change - - - - -

MAGAA Company Profile >> Back to MAGAA Efficiency Comparisons >> Compare MAGAA Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall Market #

Revenue per Employee Statistics
High Average Low
$ 88,884 $ 36,885 $ 7,449
(Dec 31 2021)   (Dec 31 2022)



Financial Statements
Yubo International Biotech Limited's Revenue MRQ $ 0 Millions Visit MAGAA's Income Statement
Yubo International Biotech Limited's Revenues TTM $ 0 Millions Visit MAGAA's aggregate revenue growth
What are MAGAA's Sales? Visit MAGAA's Sales by Segment




Other Ratios
Yubo International Biotech Limited's Income per Employee
Employees in Medical Equipment & Supplies
Medical Equipment & Supplies Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
MAGAA's Revenue per Employee versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for MAGAA's Competitors
Revenue per Employee for MAGAA's Suppliers
Revenue per Employee for MAGAA's Customers

You may also want to know
MAGAA's Sales Growth Rates MAGAA's Pe Price to earnings ratio MAGAA's Receivables Turnover Ratio MAGAA's Stock Quote
MAGAA's Net Income Growth Rates MAGAA's Ps Price to Sales ratio MAGAA's Sales per Employee MAGAA's Asset Turnover Ratio
MAGAA's Net Margin MAGAA's Pb Price to Book ratio MAGAA's Financial Strength Ratios MAGAA's Dividend Payout Ratio
Date modified: 2026-08-15T07:30:26+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Sera Prognostics Inc   972.22 $ 0.070  Million 72 
Cardio Diagnostics Holdings Inc   850.00 $ 0.014  Million 17 
Quoin Pharmaceuticals Ltd   837.83 $ 0.005  Million 6 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.